UK Court Declines To Back Phenytoin Fines

Appeals Court Ruling Upholds Decision To Refer Back To CMA

A UK appeals court has provided detailed guidance on how the country’s Competition and Markets Authority should evaluate unfair pricing, as part of a ruling that upholds a previous decision to overturn CMA fines of almost £90m ($112m) imposed on Pfizer and marketing partner Flynn Pharma over pricing for phenytoin sodium capsules.

Calculator
The appeals court offered guidance on how the CMA should evaluate unfair pricing • Source: Shutterstock

Detailed guidance on how the UK’s Competition and Markets Authority should evaluate unfair pricing has been provided as part of an appeals court ruling, which largely upholds a previous decision that overturned fines of almost £90m ($112m) imposed by the CMA on Pfizer and its marketing partner Flynn Pharma over pricing for phenytoin sodium capsules.

The fines had previously been rejected by the country’s Competition Appeal Tribunal in a 2018 decision. (Also see "UK...

More from Drug Pricing

More from Policy & Regulation

  • For Generics, A Victory Lap – And A Warning – On Drug Shortages

    Avoiding disaster at the beginning of the pandemic and offering a pro-active supply chain blueprint should position the generics industry well for an onshoring debate in Congress, but a look back at March 2020 is a reminder that even small policy shifts can have a big impact.

  • GB-Policy&Regulation-Free: Article with different widgets

    Emerging CRISPR innovations, shifting regulatory landscapes, and rising partnerships are accelerating a paradigm shift in biotech pipelines

  • Overseas API Manufacturing Identified As Key Vulnerability In US Supply Chain

    After US President Joe Biden launched a review of the country’s API supply chain, the task force has reported back with key vulnerabilities that contribute to drug shortages and supply risks during a global public health emergency. According to the report, the lack of geographic diversity and dependence on foreign nations and anti-competitive actions by foreign nations are key areas of concern.